ABS TRACT Severe acute respiratory syndrome-coronavirus-2 (SARS-COV-2), a new type of beta coronavirus that emerged in Wuhan, China, and caused a pandemic, was declared coronavirus disease-2019 (COVID-19) by the World Health Organization on February 12, 2020. Natural remedies from plants have been used traditionally for thousands of years. The global interest in drug development from natural products has grown tremendously. The interest in essential oils, which attract attention with their rich and original content, is increasing in this direction. It is thought that essential oils, which are effective against various microorganisms, may help treat COVID-19 due to their anti-inflammatory, immunomodulatory, bronchodilator, antibacterial, and antiviral properties. This review briefly describes the current biology, epidemiology, and clinical aspects of COVID-19 and essential oil's activity on SARS-COV-2 by considering its effectiveness in this field. It has been observed that most of the studies on this subject consist of in silico and in vitro studies. In this context, molecular docking studies have come into prominence. However, in vivo and clinical studies of essential oils with notable antiviral-antibacterial effects must be increased. Therefore, essential oils and their active components will be promising potential drug candidates against COVID-19, and their numbers will potentially grow. In conclusion, the present review is focused on the most common and well-known essential oils available on the pharmaceutical markets, which show visible activities, especially against enveloped viruses, including COVID-19.